Nanion Technologies and NEXEL partner to open a new reference demonstration laboratory in South Korea
April 17th 2020: Nanion Technologies GmbH, a leading provider of automated patch clamp and cell monitoring systems, anno…
April 17th 2020: Nanion Technologies GmbH, a leading provider of automated patch clamp and cell monitoring systems, anno…
Scientific Director Dr. Winston Shim and his research group aim at restoring compromised heart tissue by using stem cell…
Nanion Technologies, an innovative German-based company providing high quality devices for ion channel research and drug…
Nanion Technologies, a leading provider of automated patch clamp platforms, and Axion Biosystems, originator of the firs…
Cardiac safety assessment is a vital part of drug development since late withdrawals of compound candidates, due to hear…
Stem cell derived cardiomyocytes have tremendous potential for cardiac safety testing of drug candidates. By offering an…